Indications and Purposes
| 1 Indications And Usage Jadenu Is An Iron Chelator Indicated For The Treatment Of Chronic Iron Overload Due To Blood Transfusions In Patients 2 Years Of Age And Older. ( 1.1 ) Jadenu Is Indicated For The Treatment Of Chronic Iron Overload In Patients 10 Years Of Age And Older With Non-Transfusion-Dependent Thalassemia (Ntdt) Syndromes, And With A Liver Iron (Fe) Concentration (Lic) Of At Least 5 Mg Fe Per Gram Of Dry Weight (Fe/g Dw) And A Serum Ferritin Greater Than 300 Mcg/l. ( 1.2 ) Limitations Of Use: The Safety And Efficacy Of Jadenu When Administered With Other Iron Chelation Therapy Have Not Been Established. ( 1.3 ) 1.1 Treatment Of Chronic Iron Overload Due To Blood Transfusions (Transfusional Iron Overload) Jadenu Is Indicated For The Treatment Of Chronic Iron Overload Due To Blood Transfusions (Transfusional Hemosiderosis) In Patients 2 Years Of Age And Older. 1.2 Treatment Of Chronic Iron Overload In Non-Transfusion-Dependent Thalassemia Syndromes Jadenu Is Indicated For The Treatment Of Chronic Iron Overload In Patients 10 Years Of Age And Older With Non-Transfusion-Dependent Thalassemia (Ntdt) Syndromes And With A Liver Iron Concentration (Lic) Of At Least 5 Milligrams Of Iron Per Gram Of Liver Dry Weight (Mg Fe/g Dw) And A Serum Ferritin Greater Than 300 Mcg/l. 1.3 Limitations Of Use The Safety And Efficacy Of Jadenu When Administered With Other Iron Chelation Therapy Have Not Been Established. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Deferasirox |
|
ZINC1481815 |